Panbela Therapeutics Regains Compliance with Nasdaq Standards
Company Announcements

Panbela Therapeutics Regains Compliance with Nasdaq Standards

Panbela Therapeutics (PBLA) has released an update.

Panbela Therapeutics, Inc. has announced its return to compliance with Nasdaq’s listing requirements regarding bid price and the number of publicly held shares. This milestone is critical for the company’s continued presence on the stock market, ensuring its shares meet the necessary standards for trading and ownership distribution.

For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.

Related Articles
Christine BrownPBLA Upcoming Earnings Report: What to Expect?
TheFlyPanbela announces first patient enrolled in dose escalation study of CPP-1X-S
Christine BrownIs PBLA a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App